Literature DB >> 25579513

Reactive oxygen species as mediator of tumor radiosensitivity.

Renu Dayal, Amrita Singh, Anubhuti Pandey, Kaushala Prasad Mishra1.   

Abstract

In normal functioning of the cell, there is a balance between generation and neutralization of reactive oxygen species (ROS) by endogenous cellular defense machinery. Low levels of ROS inside the cells are required for normal functioning of the cell, which regulate signaling mechanisms involved in mitosis and apoptosis; excess of ROS production may cause oxidative stress leading to damage in vital cellular molecules, namely cytosolic lipids, proteins, and DNA. In the situation of intracellular redox imbalance, molecules of cells are altered by ROS leading to pathogenic state. It is to be noted that ROS is not only known to be involved in tumor induction and progression processes but also enhances tumor cell radiosensitivity. The level of ROS-mediated oxidative stress is linked to cellular radiosensitivity. In general, cancer cells exhibit high levels of ROS, which forms a target for selectively killing them by radiation. In this paper, we have reviewed how oxidative stress determines the radiosensitivity of tumor cells involving ROS in the mechanism of radiation induced tumor cell killing. It is suggested that radiation-induced ROS play a key role in the mechanism of tumor cell killing by altering the signaling network and triggering of apoptosis. Furthermore, it is pointed out that combined use of plant-derived antioxidants and radiation enhance overproduction of ROS in tumor cells leading to enhanced radiosensitivity, which may find practical applications in clinic.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25579513     DOI: 10.4103/0973-1482.146073

Source DB:  PubMed          Journal:  J Cancer Res Ther        ISSN: 1998-4138            Impact factor:   1.805


  23 in total

Review 1.  Profiles of Radioresistance Mechanisms in Prostate Cancer.

Authors:  Luksana Chaiswing; Heidi L Weiss; Rani D Jayswal; Daret K St Clair; Natasha Kyprianou
Journal:  Crit Rev Oncog       Date:  2018

Review 2.  Association between radiation-induced cell death and clinically relevant radioresistance.

Authors:  Yoshikazu Kuwahara; Kazuo Tomita; Yusuke Urushihara; Tomoaki Sato; Akihiro Kurimasa; Manabu Fukumoto
Journal:  Histochem Cell Biol       Date:  2018-09-20       Impact factor: 4.304

3.  Molecular ablation of tumor blood vessels inhibits therapeutic effects of radiation and bevacizumab.

Authors:  Viveka Nand Yadav; David Altshuler; Padma Kadiyala; Daniel Zamler; Andrea Comba; Henry Appelman; Patrick Dunn; Carl Koschmann; Maria G Castro; Pedro R Löwenstein
Journal:  Neuro Oncol       Date:  2018-09-03       Impact factor: 12.300

4.  UV Light-Activated GdYVO4:Eu3+ Nanoparticles Induce Reactive Oxygen Species Generation in Leukocytes Without Affecting Erythrocytes In Vitro.

Authors:  Anatolii Onishchenko; Valeriy Myasoedov; Svetlana Yefimova; Oksana Nakonechna; Volodymyr Prokopyuk; Dmytro Butov; Umut Kökbaş; Vladimir Klochkov; Pavel Maksimchuk; Nataliya Kavok; Anton Tkachenko
Journal:  Biol Trace Elem Res       Date:  2021-08-13       Impact factor: 3.738

5.  Serum Dyslipidemia Is Induced by Internal Exposure to Strontium-90 in Mice, Lipidomic Profiling Using a Data-Independent Liquid Chromatography-Mass Spectrometry Approach.

Authors:  Maryam Goudarzi; Waylon M Weber; Juijung Chung; Melanie Doyle-Eisele; Dunstana R Melo; Tytus D Mak; Steven J Strawn; David J Brenner; Raymond Guilmette; Albert J Fornace
Journal:  J Proteome Res       Date:  2015-08-18       Impact factor: 4.466

Review 6.  Targeting the signaling in Epstein-Barr virus-associated diseases: mechanism, regulation, and clinical study.

Authors:  Ya Cao; Longlong Xie; Feng Shi; Min Tang; Yueshuo Li; Jianmin Hu; Lin Zhao; Luqing Zhao; Xinfang Yu; Xiangjian Luo; Weihua Liao; Ann M Bode
Journal:  Signal Transduct Target Ther       Date:  2021-01-12

7.  M2 macrophages are more resistant than M1 macrophages following radiation therapy in the context of glioblastoma.

Authors:  Marine M Leblond; Elodie A Pérès; Charly Helaine; Aurélie N Gérault; Damien Moulin; Clément Anfray; Didier Divoux; Edwige Petit; Myriam Bernaudin; Samuel Valable
Journal:  Oncotarget       Date:  2017-08-07

8.  The polo-like kinase 1 inhibitor volasertib synergistically increases radiation efficacy in glioma stem cells.

Authors:  Jianwen Dong; Soon Young Park; Nghi Nguyen; Ravesanker Ezhilarasan; Emmanuel Martinez-Ledesma; Shaofang Wu; Verlene Henry; Yuji Piao; Ningyi Tiao; David Brunell; Clifford Stephan; Roel Verhaak; Erik Sulman; Veerakumar Balasubramaniyan; John F de Groot
Journal:  Oncotarget       Date:  2018-01-08

9.  Ganoderic acid T improves the radiosensitivity of HeLa cells via converting apoptosis to necroptosis.

Authors:  Chang-Sheng Shao; Na Feng; Shuai Zhou; Xin-Xin Zheng; Peng Wang; Jing-Song Zhang; Qing Huang
Journal:  Toxicol Res (Camb)       Date:  2021-05-13       Impact factor: 3.524

10.  A Radiosensitizing Inhibitor of HIF-1 alters the Optical Redox State of Human Lung Cancer Cells In Vitro.

Authors:  David E Lee; Kinan Alhallak; Samir V Jenkins; Isaac Vargas; Nicholas P Greene; Kyle P Quinn; Robert J Griffin; Ruud P M Dings; Narasimhan Rajaram
Journal:  Sci Rep       Date:  2018-06-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.